Number needed to treat with rosuvastatin to prevent first cardiovascular events and death among men and women with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: Justification for the use of statins in prevention: An intervention trial evaluating rosuvastatin (JUPITER) Academic Article uri icon

Overview

MeSH Major

  • C-Reactive Protein
  • Cholesterol, LDL
  • Fluorobenzenes
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Myocardial Infarction
  • Pyrimidines
  • Stroke
  • Sulfonamides

abstract

  • clinicaltrials.gov. Identifier NCT00239681.

publication date

  • November 2009

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1161/CIRCOUTCOMES.109.848473

PubMed ID

  • 20031900

Additional Document Info

start page

  • 616

end page

  • 23

volume

  • 2

number

  • 6